QOOLABS INC — Department of Health and Human Services SBIR Phase II: ODCDC
QOOLABS INC — SBIR Phase II award from Department of Health and Human Services.
Phase II SBIR prototype / development signal
- Phase II is where Department of Health and Human Services funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
- Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
- Obligated amount $718,000 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
- Topic code ODCDC links this award to a solicitation family — search the same topic stem for incumbents and recompete timing.
- Amount
- $718,000
- Agency
- Department of Health and Human Services · Centers for Disease Control and Prevention
- Program / Phase
- SBIR · Phase II
- Topic
- ODCDC
- NAICS
- —
- Place of performance
- CA
- Period
- —
Description
HCV infects about of the world s population and most people are unaware of their infection status About of individuals with HCV infection develop chronic hepatitis and many progress to have cirrhosis and hepatocellular carcinoma HCC An early diagnosis in the course of the disease not only increases the chances of successful treatment but also effectively limits further transmission of HCV A rapid test that can be used for screening purposes will further improve the diagnosis rate and effectively prevent HCV infection transmission Unfortunately there are no rapid tests currently available for speedy diagnosis of HCV infection Qoolabs has developed a proprietary technology platform for isolating highly specific single domain antibodies and successfully applied these antibodies on lateral flow immunoassays LFIA In this study we propose to use this technology to develop HCV core antigen specific antibodies and to produce LFIA devices for rapid and early diagnosis of HCV